about
Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresiaHyperthyroidism and pregnancyCategorical and noncategorical modes of speech perception along the voicing continuumMaternal perchlorate levels in women with borderline thyroid function during pregnancy and the cognitive development of their offspring: data from the Controlled Antenatal Thyroid Study.Unusual complications of thyroid carcinoma.Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women.Aetiology of hyperthyroidism in Canada and Wales.Thyroid hormone and intellectual development: a clinician's view.Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.Thyroid disorders--an update.Thyroid disease in relation to pregnancy: a decade of change.Iodine status of UK schoolgirls: a cross-sectional survey.Clinical aspects of recurrent postpartum thyroiditis.Therapy of endocrine disease: Impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis.Determinants of free theophylline clearance in asthmaThe effect of thyrotoxicosis on isoniazid acetylation.2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.Postpartum thyroiditis.Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone.Thyroid dysfunction: reproduction and postpartum thyroiditis.Screening for thyroid dysfunction in pregnancy: is it worthwhile?Subclinical hypothyroidism: the case for treatment.Orbital decompression for Graves' orbitopathy in EnglandConsequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknownsAspects of treatment of subclinical hypothyroidism.Iritis after treatment with streptokinase.Antenatal thyroid screening and childhood cognitive function.Pre-conception counselling in graves' disease.Lithium and thyroid.Iodine status in europe in 2014.Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia.Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists.Important considerations in the management of Graves' disease in pregnant women.Should all women be screened for thyroid dysfunction in pregnancy?Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.Maturation in serum thyroid function parameters over childhood and puberty: results of a longitudinal study.Current trends in antithyroid drug treatment of Graves' disease.Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.Current challenges in the pharmacological management of thyroid dysfunction in pregnancy.
P50
Q24322560-80822F3B-5A9A-4D4D-BC1E-AE50A07A1CD6Q24650720-3F6DBE33-B36F-44EA-B67F-820B2988E697Q30459969-E9311DE7-FF2F-40F3-A99B-22F1DDC9996AQ30838369-AEA33C5E-7538-4490-9DAA-565EA9D39CF5Q33148549-BD0A94AE-7179-4CAC-9E72-4775D41CA5C5Q33567523-1A53ACAF-F0F7-4470-94D6-D4E879F1FD6EQ33685015-E53467C5-C41C-41A0-9021-AF4E1F53F61CQ33710927-D9C58E94-BB0C-46BD-A971-41A9A7FDDB4BQ34010116-FAD954AE-3570-48BE-9394-28EA5DCE3385Q34017873-5753575E-57DE-4802-8CC7-7BF8ADE1181EQ34022499-B50509BE-E8C7-4F1F-8A43-EC543FE288B8Q34189731-F41C7AA1-A42C-4BD1-90C1-B4E08F579F17Q34214600-5DA65F8F-1175-44E8-89E9-666E2D6BB0AAQ34374934-68599EE7-A322-41A1-9B7D-7A8E43E19410Q34417136-56509313-FB62-4B68-A086-A078578A6A25Q34417794-05C44706-4782-4979-9212-DA112ED76308Q34548616-8850504C-8369-495B-9085-36AE9A9D3F85Q34975553-FBC283F6-F822-4E4D-88C2-EE6C79D8DC46Q34990807-53155B61-1C35-4046-A06C-249D18A8D5FCQ35049049-F3378B78-6E34-4DCE-B061-4AD533886DDFQ35099211-3EA1A5A4-7DCB-41EC-B1C6-C1DAC3A9E058Q35188672-109D0D04-70FE-4F69-89F6-656C0886BBC1Q35820372-EED2A0CB-E92C-4721-88FF-56058696B31CQ36106152-E4CDEC1C-94B4-43FB-A13F-BCA16C142A3CQ36804695-EEFFB11B-26E7-4FC4-93EA-7BE6E05BF74FQ36886206-DD9198BD-4B9B-4BD6-90AF-E03D0B67CE12Q37270355-A373251C-1660-4CD9-AD25-3FE45D8C3899Q37290835-14DFBC36-A9EB-4B2A-B323-621FA458C657Q37639654-A3AA123F-C4CA-4D54-BFE2-4AB022DD3306Q37733481-22F9ACB0-C04C-410E-ACB0-27EF4205B618Q38013212-615D13D0-9C52-490C-AB3F-F9BB1AF51932Q38265100-BCA55F25-B348-49B7-8494-2519B46C1B04Q38285063-F3B476D1-2BFA-4A49-A0A2-17DBA43D3E5BQ38515111-CC7BDCCC-3133-4F77-A990-9791C7BA839CQ38535361-71CEBCED-D911-4860-9065-23B3F52060CCQ38692635-3C3EC702-F2A9-47C0-A152-3C0A530C4F3EQ38804128-7F3189AC-AD0E-4257-86F2-A33DB54BAA2BQ38822451-54E2B7EA-B0E2-448D-B9FC-FD6DD953A3FEQ38906232-332AA7B0-C6B7-493B-97B0-D313063D3464Q38990879-DAB6E53F-C16D-4867-BC0E-85E3A35A2134
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John H Lazarus
@ast
John H Lazarus
@en
John H Lazarus
@es
John H Lazarus
@nl
John H Lazarus
@sl
type
label
John H Lazarus
@ast
John H Lazarus
@en
John H Lazarus
@es
John H Lazarus
@nl
John H Lazarus
@sl
altLabel
John Lazarus
@en
prefLabel
John H Lazarus
@ast
John H Lazarus
@en
John H Lazarus
@es
John H Lazarus
@nl
John H Lazarus
@sl
P1053
H-5108-2017
P106
P31
P496
0000-0001-8852-704X